150 related articles for article (PubMed ID: 25676387)
21. Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer's disease: future directions.
Carlsson CM
J Alzheimers Dis; 2008 Oct; 15(2):327-38. PubMed ID: 18953117
[TBL] [Abstract][Full Text] [Related]
22. The impact of alcohol on Alzheimer's disease: a systematic review.
Piazza-Gardner AK; Gaffud TJ; Barry AE
Aging Ment Health; 2013; 17(2):133-46. PubMed ID: 23171229
[TBL] [Abstract][Full Text] [Related]
23. Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
Langbaum JB; Zissimopoulos J; Au R; Bose N; Edgar CJ; Ehrenberg E; Fillit H; Hill CV; Hughes L; Irizarry M; Kremen S; Lakdawalla D; Lynn N; Malzbender K; Maruyama T; Massett HA; Patel D; Peneva D; Reiman EM; Romero K; Routledge C; Weiner MW; Weninger S; Aisen PS
Alzheimers Dement; 2023 Feb; 19(2):696-707. PubMed ID: 35946590
[TBL] [Abstract][Full Text] [Related]
24. Building a roadmap for developing combination therapies for Alzheimer's disease.
Perry D; Sperling R; Katz R; Berry D; Dilts D; Hanna D; Salloway S; Trojanowski JQ; Bountra C; Krams M; Luthman J; Potkin S; Gribkoff V; Temple R; Wang Y; Carrillo MC; Stephenson D; Snyder H; Liu E; Ware T; McKew J; Fields FO; Bain LJ; Bens C
Expert Rev Neurother; 2015 Mar; 15(3):327-33. PubMed ID: 25708309
[TBL] [Abstract][Full Text] [Related]
25. The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.
Beekly DL; Ramos EM; van Belle G; Deitrich W; Clark AD; Jacka ME; Kukull WA;
Alzheimer Dis Assoc Disord; 2004; 18(4):270-7. PubMed ID: 15592144
[TBL] [Abstract][Full Text] [Related]
26. Treating Alzheimer's disease: do clinical trial methods produce unnecessary practitioner dilemmas?
Becker RE
Am J Alzheimers Dis Other Demen; 2006; 21(2):81-4. PubMed ID: 16634462
[TBL] [Abstract][Full Text] [Related]
27. The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
LaRocca NG; Hudson LD; Rudick R; Amtmann D; Balcer L; Benedict R; Bermel R; Chang I; Chiaravalloti ND; Chin P; Cohen JA; Cutter GR; Davis MD; DeLuca J; Feys P; Francis G; Goldman MD; Hartley E; Kapoor R; Lublin F; Lundstrom G; Matthews PM; Mayo N; Meibach R; Miller DM; Motl RW; Mowry EM; Naismith R; Neville J; Panagoulias J; Panzara M; Phillips G; Robbins A; Sidovar MF; Smith KE; Sperling B; Uitdehaag BM; Weaver J;
Mult Scler; 2018 Oct; 24(11):1469-1484. PubMed ID: 28799444
[TBL] [Abstract][Full Text] [Related]
28. Concise informed consent to increase data and biospecimen access may accelerate innovative Alzheimer's disease treatments.
Hake AM; Dacks PA; Arnerić SP;
Alzheimers Dement (N Y); 2017 Nov; 3(4):536-541. PubMed ID: 29124112
[TBL] [Abstract][Full Text] [Related]
29. The Health Outreach Program for the Elderly (HOPE) database.
Siwek D
Alzheimer Dis Assoc Disord; 1999; 13 Suppl 1():S101-5. PubMed ID: 10369528
[TBL] [Abstract][Full Text] [Related]
30. The Patient in Your Alzheimer's Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer's Disease.
Shiovitz T; Steinmiller B; Steinmetz C; Perez S; Oseas R
J Prev Alzheimers Dis; 2020; 7(1):43-46. PubMed ID: 32010925
[TBL] [Abstract][Full Text] [Related]
31. Lessons from Darwin: evolutionary biology's implications for Alzheimer's disease research and patient care.
Becker RE
Curr Alzheimer Res; 2005 Jul; 2(3):319-26. PubMed ID: 15974897
[TBL] [Abstract][Full Text] [Related]
32. Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.
Vellas B
J Nutr Health Aging; 2012 Apr; 16(4):330. PubMed ID: 22499451
[No Abstract] [Full Text] [Related]
33. Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development.
Wessels AM; Edgar CJ; Nathan PJ; Siemers ER; Maruff P; Harrison J
Drug Discov Today; 2021 May; 26(5):1330-1336. PubMed ID: 33486115
[TBL] [Abstract][Full Text] [Related]
34. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.
Kaye J; Aisen P; Amariglio R; Au R; Ballard C; Carrillo M; Fillit H; Iwatsubo T; Jimenez-Maggiora G; Lovestone S; Natanegara F; Papp K; Soto ME; Weiner M; Vellas B
J Prev Alzheimers Dis; 2021; 8(4):513-519. PubMed ID: 34585227
[TBL] [Abstract][Full Text] [Related]
35. MouseBytes, an open-access high-throughput pipeline and database for rodent touchscreen-based cognitive assessment.
Beraldo FH; Palmer D; Memar S; Wasserman DI; Lee WV; Liang S; Creighton SD; Kolisnyk B; Cowan MF; Mels J; Masood TS; Fodor C; Al-Onaizi MA; Bartha R; Gee T; Saksida LM; Bussey TJ; Strother SS; Prado VF; Winters BD; Prado MA
Elife; 2019 Dec; 8():. PubMed ID: 31825307
[TBL] [Abstract][Full Text] [Related]
36. The Rationale for Radiation Therapy in Alzheimer's Disease.
Wilson GD; Rogers CL; Mehta MP; Marples B; Michael DB; Welsh JS; Martinez AA; Fontanesi J
Radiat Res; 2023 May; 199(5):506-516. PubMed ID: 36881804
[TBL] [Abstract][Full Text] [Related]
37. Clinical trials with novel treatments of Alzheimer's disease.
Spiegel R; Gray J
Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():410A-411A. PubMed ID: 1498894
[No Abstract] [Full Text] [Related]
38. Lessons from Alzheimer's Disease (AD) Clinical Trials: Instead of "A-Drug", AD-D prevention to Avert AD.
Lahiri DK
Curr Alzheimer Res; 2019; 16(4):279-280. PubMed ID: 31104627
[No Abstract] [Full Text] [Related]
39. [A reasoned approach to the pharmacologic treatment of Alzheimer's disease].
Espinàs J; Monjo M
Aten Primaria; 1998 Jan; 21(1):60-2. PubMed ID: 9557363
[No Abstract] [Full Text] [Related]
40. Use of External Controls in Regulatory Decision-Making.
Jarow JP
Clin Pharmacol Ther; 2017 May; 101(5):595-596. PubMed ID: 28182270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
